Breast cancer is highly influenced by genes and can run in families. Humans possess certain genes that are protective against cancer. However, inheriting faulty versions or variants of these genes increases the risk of developing cancer. Variants of BRCA1 and BRCA2 increases chances of developing breast cancer and ovarian cancer. Thus, predictive genetic tests are conducted to identify the variants of these genes.
MARKET DYNAMICS
The predictive breast cancer gene testing market is driving due to the increasing incidence of breast cancer, and availability of advanced technologically and treatment options. Moreover, growing awareness regarding breast cancer among the population in developed as well as developing countries is likely to create growth opportunities in the market.
MARKET SCOPE
The "Predictive Breast Cancer Gene Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of predictive breast cancer gene testing market with detailed market segmentation by type, gene types and end user. The predictive breast cancer gene testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in predictive breast cancer gene testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The predictive breast cancer gene testing market is segmented on the basis of type, gene types and end user. Based on type the market is segmented family history, age group, and gender. Gene types segment is segmented into high penetrant genes, intermediate penetrant genes, and low penetrant genes. Based on end user the market is segmented into clinical laboratories, cancer hospitals, and research laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the predictive breast cancer gene testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The predictive breast cancer gene testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting predictive breast cancer gene testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Predictive Breast Cancer Gene Testing market in these regions.
MARKET PLAYERS
The report covers key developments in the predictive breast cancer gene testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from predictive breast cancer gene testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for predictive breast cancer gene testing in the global market. Below mentioned is the list of few companies engaged in the predictive breast cancer gene testing market.
The report also includes the profiles of key players in predictive breast cancer gene testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Roche
- Thermo Fisher Scientific
- PerkinElmer
- Quest Diagnostics
- Myriad Genetics
- Iverson Genetics
- Cancer Genetics
- OncoCyte Corporation
- NeoGenomics
- Invitae
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.